| Closed to accrual |
| HPTN 035 | 10065 | Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO2000/5 Gel (P) for the Prevention of HIV Infection in Women | |
| HPTN 059 | 10145 | Phase II Expanded Safety and Acceptability Study of the Vaginal Microbicide 1% Tenofovir Gel | |
| Enrolling |
| MTN-015 | 10529 | An Observational Cohort Study of Women following HIV-1 Seroconversion in Microbicide Trials | |
| MTN-002 | 10600 | Phase I Study of the Maternal Single-Dose Pharmacokinetics and Placental Transfer of Tenofovir 1% Vaginal Gel among Healthy Term Gravidas | |
| MTN-001 | 10617 | Phase 2 Adherence and Pharmacokinetics Study of Oral and Vaginal Preparations of Tenofovir | |
| MTN-004 | 10492 | Phase 1 Study of the Safety and Acceptability of 3% w/w SPL7013 Gel (VivaGelTM) Applied Vaginally in Sexually Active Young Women | |
| In development |
| MTN-003 | 10622 | VOICE Study – Vaginal and Oral Interventions to Control the Epidemic | |
| MTN-005 | 10635 | Expanded Safety and Acceptability Study of a Non-medicated Intravaginal Ring | |
| MTN-003B | 10709 | Bone Mineral Density Substudy | |